diaDexus Company Profile (OTCMKTS:DDXS)

About diaDexus

diaDexus logodiaDexus, Inc. (diaDexus), incorporated on November 27, 1995, is a medical diagnostics company. The Company is focused on the development and commercialization of in vitro diagnostic products addressing unmet needs in cardiovascular disease. The Company's product, the PLAC Test, helps identify individuals suffering a heart attack or stroke. The Company's PLAC Test measures Lp-PLA2, which is a vascular-specific inflammatory marker implicated in the formation of rupture-prone plaque. The PLAC Test is a blood test, available nationally through clinical reference, hospital and advanced cardiovascular diagnostic laboratories. The PLAC Test is an actionable tool and a valuable guide for patient management that motivates therapeutic changes in lifestyle, enables you to set treatment goals and determine how aggressively you should treat risk factors and may create a greater sense of urgency in patients to be compliant with treatment recommendations when they understand there is active disease present and not just risk of disease.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: DDXS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.01
  • 50 Day Moving Average: $1.105
  • 200 Day Moving Average: $1.538
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.01
  • P/E Growth: 0.000
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for diaDexus (OTCMKTS:DDXS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for diaDexus (OTCMKTS:DDXS)
DateFirmActionRatingPrice TargetDetails
8/14/2015Feltl & Co.DowngradeBuy -> HoldView Rating Details
2/19/2015Ladenburg ThalmannUpgradeBuyView Rating Details
(Data available from 8/24/2014 forward)


Earnings History for diaDexus (OTCMKTS:DDXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2015($0.69)($0.34)ViewN/AView Earnings Details
8/13/2015($0.29)($0.87)ViewN/AView Earnings Details
5/12/2015Q115($0.04)($0.02)$5.23 millionViewN/AView Earnings Details
3/11/2015($0.02)($0.04)ViewN/AView Earnings Details
11/5/2014($0.01)($0.03)ViewN/AView Earnings Details
7/28/2014($0.02)($0.01)ViewN/AView Earnings Details
5/7/2014($0.03)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for diaDexus (OTCMKTS:DDXS)
Current Year EPS Consensus Estimate: $-1.500 EPS
Next Year EPS Consensus Estimate: $-1.500 EPS


Dividend History for diaDexus (OTCMKTS:DDXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for diaDexus (OTCMKTS:DDXS)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for diaDexus (OTCMKTS:DDXS)
finance.yahoo.com logo2:08 pm Thinly traded OTC name DIADEXUS is filing for relief under Chapter 7 of Title 11 of the US Bankruptcy Code in order to initiate an orderly liquidation of the assets of the Company (OTCMKTS:DDXS)
finance.yahoo.com - June 10 at 2:08 PM
finance.yahoo.com logoDiadexus, Inc. to File Chapter 7 (OTCMKTS:DDXS)
finance.yahoo.com - June 10 at 2:06 PM
capitalcube.com logoDiadexus, Inc. :DDXS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 (OTCMKTS:DDXS)
www.capitalcube.com - June 1 at 3:35 PM


diaDexus (OTCMKTS:DDXS) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by MarketBeat.com Staff